These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2161097)

  • 1. EIa-mediated transactivation of the adenovirus EIIa early promoter is restricted in undifferentiated F9 cells.
    Boeuf H; Jansen-Durr P; Kédinger C
    Oncogene; 1990 May; 5(5):691-9. PubMed ID: 2161097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of the E2F transcription factor by the adenovirus EIa and EIV products in F9 cells.
    Boeuf H; Reimund B; Jansen-Durr P; Kédinger C
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1782-6. PubMed ID: 2137928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative binding of two E2F molecules to an Ela-responsive promoter is triggered by the adenovirus Ela, but not by a cellular Ela-like activity.
    Jansen-Durr P; Boeuf H; Kédinger C
    EMBO J; 1989 Nov; 8(11):3365-70. PubMed ID: 2531078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rb may act as a transcriptional co-activator in undifferentiated F9 cells.
    Bocco JL; Reimund B; Chatton B; Kedinger C
    Oncogene; 1993 Nov; 8(11):2977-86. PubMed ID: 8414500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct cellular proteins interact with the EIa-responsive element of an adenovirus early promoter.
    Jansen-Durr P; Wintzerith M; Reimund B; Hauss C; Kédinger C
    J Virol; 1990 May; 64(5):2384-7. PubMed ID: 2139142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products.
    Hen R; Borrelli E; Fromental C; Sassone-Corsi P; Chambon P
    Nature; 1986 May 15-21; 321(6067):249-51. PubMed ID: 3012353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The function of inducible promoter systems in F9 embryonal carcinoma cells.
    Miller K; Rizzino A
    Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EIa-mediated stimulation of the adenovirus EIII promoter involves an enhancer element within the nearby EIIa promoter.
    Zajchowski DA; Jalinot P; Kedinger C
    J Virol; 1988 May; 62(5):1762-7. PubMed ID: 2965764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of host and viral genes by the adenovirus E1B 19K tumor antigen.
    Herrmann CH; Dery CV; Mathews MB
    Oncogene; 1987; 2(1):25-35. PubMed ID: 2963990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulatory sequences in the EIa-inducible enhancer of the adenovirus-2 early EIIa promoter.
    Jalinot P; Kédinger C
    Nucleic Acids Res; 1986 Mar; 14(6):2651-69. PubMed ID: 3008095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenovirus-5 12S E1a protein, but not the 13S induces expression of the endoA differentiation marker in F9 cells.
    Velcich A; Ziff EB
    Oncogene; 1989 Jun; 4(6):707-13. PubMed ID: 2543941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor.
    La Thangue NB; Thimmappaya B; Rigby PW
    Nucleic Acids Res; 1990 May; 18(10):2929-38. PubMed ID: 2140887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adenovirus EII early promoter has multiple EIA-sensitive elements, two of which function cooperatively in basal and virus-induced transcription.
    Manohar CF; Kratochvil J; Thimmapaya B
    J Virol; 1990 Jun; 64(6):2457-66. PubMed ID: 2139891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific activation of transcription by adenovirus EIa products is observed in HeLa cells but not in 293 cells.
    Leff T; Chambon P
    Mol Cell Biol; 1986 Jan; 6(1):201-8. PubMed ID: 2946930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells.
    Okuda A; Fukushima A; Nishimoto M; Orimo A; Yamagishi T; Nabeshima Y; Kuro-o M; Nabeshima Yi; Boon K; Keaveney M; Stunnenberg HG; Muramatsu M
    EMBO J; 1998 Apr; 17(7):2019-32. PubMed ID: 9524124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the transforming growth factor-beta 2 gene promoter in embryonal carcinoma cells and their differentiated cells: differential utilization of transcription factors.
    Kelly D; Scholtz B; Orten DJ; Hinrichs SH; Rizzino A
    Mol Reprod Dev; 1995 Feb; 40(2):135-45. PubMed ID: 7766406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
    Swaminathan S; Thimmapaya B
    J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ; Roman A
    Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abundance and in vitro DNA binding of three cellular proteins interacting with the adenovirus EIIa early promoter are not modified by the EIa gene products.
    Jalinot P; Devaux B; Kédinger C
    Mol Cell Biol; 1987 Oct; 7(10):3806-17. PubMed ID: 2960885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.